Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
REjtmUjn0eKVxw56
